Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The aim of this pilot study is to assess the methodology, practical arrangements and
pulmonary absorption with charcoal blockage for the future bioequivalence studies. In
addition, PK of budesonide and formoterol after administration from 2 different batches of
Symbicort TH is compared with each other.
Phase:
Phase 1
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Charcoal Formoterol Fumarate